ovel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer.

Not Applicable

• Conditions: gastrointestinal cancer treated with oxaliplatin-based chemotherapy

• Registration Number: JPRN-UMIN000039697
• Lead Sponsor: Hokkaido university hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-05
• Study Completion: 2022-06-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who have received Oxaliplatin in past treatment. 2) Patients with cirrhosis or chronic hepatitis. 3) Case after liver resection. 4) Case after splenectomy.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is a probability that a high score of HokUS-10 and the increases in spleen volume of computed tomography are observed in the same case.

Secondary Outcome Measures

Name	Time	Method
The secondary endpoint is a probability that a high score of HokUS-10 and the diagnosis of SOS/VOD based on histopathological findings are observed in the same case.